1 From the Department of Medical Genetics, The Western Pennsylvania Hospital, and the University of Pittsburgh, Pittsburgh; the Biochemical Diseases Clinical Service and the Biochemical Diseases Laboratory, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada; and the Department of Pediatrics, University of Zurich, Zurich
A deficiency of hepatic guanosine triphosphate cyclohydrolase I is reported in a 4-month-old infant in whom positive results on a Guthrie phenylketonuria test in the neonatal period were found. Because of the significantly elevated serum phenylalanine levels a diagnosis of classical phenylketonuria was made, and dietary therapy was started. Urinary pteridine screening for cofactor variants, however, revealed extremely low levels of both neopterin and biopterin. This suggested the possibility of guanosine triphosphate cyclohydrolase I deficiency and led to additional confirmatory assays. Repeat urine, serum, and CSF pteridine profiles, combined with tetrahydrobiopterin-loading studies and the assay of guanosine triphosphate cyclohydrolase I activity in a liver biopsy, confirmed the defect. It is significant to note that the diagnosis was made before the onset of major clinical symptoms. This case illustrates the need for routine cofactor variant screening of all infants in whom hyperphenylalaninemia is diagnosed in the neonatal period.
Key Words: guanosine triphosphat cyclohydrolase I deficiency hyperphenylalaninemia routine urine pteridine screening
Submitted on February 18, 1986
Accepted on April 28, 1986
This article has been cited by other articles:
![]() |
H. Ichinose, T. Ohye, Y. Matsuda, T.-a. Hori, N. Blau, A. Burlina, B. Rouse, R. Matalon, K. Fujita, and T. Nagatsu Characterization of Mouse and Human GTP Cyclohydrolase I Genes J. Biol. Chem., April 28, 1995; 270(17): 10062 - 10071. [Abstract] [Full Text] [PDF] |
||||